The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No.26
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte TIMOTHY P. KOGAN, KAIJUN REN,
PETER VANDERSLICE, and PAMELA J. BECK
__________
Appeal No. 2001-0137
Application No. 08/646,558
__________
ON BRIEF
__________
Before WILLIAM F. SMITH, ADAMS and GRIMES, Administrative Patent Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s
final rejection of claims 32-37, 40-59, and 63. The examiner has indicated that
the other pending claims (38, 39, 60, and 61) are “allowable, except for Seq. ID.
No. 26.” Examiner’s Answer, page 24. Claim 32 is representative of the claims
on appeal and reads as follows:
32. An isolated and purified cyclic peptide of from 5 to about 8 amino
acid residues that inhibits the binding of the integrin α4β1 to VCAM-
1 or fibronectin, the peptide having (a) an N-terminal amine group,
acetyl group or polyethyleneglycol moiety of from about 400 to
about 12,000 Daltons average molecular weight linked through an
amide bond to the N-terminal residue; and (b) a C-terminal
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: November 3, 2007